- Report
- August 2022
- 120 Pages
Global
From €4334EUR$4,750USD£3,683GBP
- Report
- February 2024
- 120 Pages
Global
From €4334EUR$4,750USD£3,683GBP
- Report
- November 2023
- 81 Pages
Germany
From €3194EUR$3,500USD£2,714GBP
- Report
- April 2023
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- May 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- May 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- May 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- May 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- May 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- March 2024
- 200 Pages
Global
From €3787EUR$4,150USD£3,218GBP
- Report
- August 2023
- 145 Pages
Global
From €2874EUR$3,150USD£2,442GBP
- Report
- January 2024
- 146 Pages
Global
From €3878EUR$4,250USD£3,295GBP
- Report
- December 2023
- 145 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- December 2023
- 148 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- October 2023
- 152 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- October 2023
- 152 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- April 2024
- 300 Pages
Global
From €4061EUR$4,450USD£3,450GBP
- Report
- April 2024
- 82 Pages
Middle East, Africa
From €3148EUR$3,450USD£2,675GBP
- Report
- April 2024
- 89 Pages
North America
From €3148EUR$3,450USD£2,675GBP
- Report
- April 2024
- 101 Pages
Europe
From €3148EUR$3,450USD£2,675GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more